ARCHIVES

NIC Grants Appeals Process Explained

This article is from The Cancer Letter archive.

Vol. 11 No. 16 | April 19, 1985

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

In Brief: Bishop Named Interim Chairman of NCAB; AACI Elects Wicha president, Herberman VP

December 12, 1997

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Advocacy: NCCS, ASCO Petition FDA To Set Standards For Expanded Access Programs.

April 14, 2006

RFA: Native American Women’s Cancer Initiative

July 9, 1993

DCCP Board Defers Two Concept Requests, Approves Sole Sources

October 22, 1982